These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19893602)

  • 1. Experimental and clinical studies on fluoroquinolone-insusceptible Escherichia coli isolated from patients with urinary tract infections from 1994 to 2007.
    Wada K; Kariyama R; Mitsuhata R; Uehara S; Watanabe T; Monden K; Kumon H
    Acta Med Okayama; 2009 Oct; 63(5):263-72. PubMed ID: 19893602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and mechanisms of fluoroquinolone resistance in 156 Escherichia coli strains clinically isolated from urinary tract infections.
    Yasufuku T; Shigemura K; Shirakawa T; Nakano Y; Tanaka K; Arakawa S; Kinoshita S; Nishimura K; Kawabata M; Fujisawa M
    Scand J Infect Dis; 2011 Feb; 43(2):83-8. PubMed ID: 20942776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens.
    Chenia HY; Pillay B; Pillay D
    J Antimicrob Chemother; 2006 Dec; 58(6):1274-8. PubMed ID: 17040923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of fluoroquinolone-resistant Escherichia coli strains isolated from urine clinical samples.
    Dehbanipour R; Khanahmad H; Sedighi M; Bialvaei AZ; Faghri J
    J Prev Med Hyg; 2019 Mar; 60(1):E25-E30. PubMed ID: 31041407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
    Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M
    Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolone-Resistant Sequence Type 131 Subgroups O25b and O16 Among Extraintestinal Escherichia coli Isolates from Community-Acquired Urinary Tract Infections.
    Hefzy EM; Hassuna NA
    Microb Drug Resist; 2017 Mar; 23(2):224-229. PubMed ID: 27214282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli.
    Rattanaumpawan P; Nachamkin I; Bilker WB; Roy JA; Metlay JP; Zaoutis TE; Lautenbach E;
    Ann Clin Microbiol Antimicrob; 2017 Apr; 16(1):25. PubMed ID: 28390438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical analysis of bacterial strain profiles isolated from urinary tract infections: A 30-year study.
    Wada K; Uehara S; Yamamoto M; Sadahira T; Mitsuhata R; Araki M; Kobayashi Y; Ishii A; Kariyama R; Watanabe T; Nasu Y; Kumon H
    J Infect Chemother; 2016 Jul; 22(7):478-82. PubMed ID: 27217185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
    Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
    J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolone resistance mechanisms in multidrug-resistant Escherichia coli isolated from extraintestinal infections in dogs.
    Gibson JS; Cobbold RN; Kyaw-Tanner MT; Heisig P; Trott DJ
    Vet Microbiol; 2010 Nov; 146(1-2):161-6. PubMed ID: 20471187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinolone resistance and ornithine decarboxylation activity in lactose-negative Escherichia coli.
    Gomig F; Galvão CW; Freitas DL; Labas L; Etto RM; Esmerino LA; Lima MA; Appel MH; Zanata SM; Steffens MB; Nader HB; Silveira RB
    Braz J Microbiol; 2015; 46(3):753-7. PubMed ID: 26413057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide transcriptome analysis of fluoroquinolone resistance in clinical isolates of Escherichia coli.
    Yamane T; Enokida H; Hayami H; Kawahara M; Nakagawa M
    Int J Urol; 2012 Apr; 19(4):360-8. PubMed ID: 22211478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary Tract Physiological Conditions Promote Ciprofloxacin Resistance in Low-Level-Quinolone-Resistant Escherichia coli.
    Martín-Gutiérrez G; Rodríguez-Beltrán J; Rodríguez-Martínez JM; Costas C; Aznar J; Pascual Á; Blázquez J
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4252-8. PubMed ID: 27139482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
    Ejrnæs K
    Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
    Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
    Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.
    Johnson L; Sabel A; Burman WJ; Everhart RM; Rome M; MacKenzie TD; Rozwadowski J; Mehler PS; Price CS
    Am J Med; 2008 Oct; 121(10):876-84. PubMed ID: 18823859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolone and Third-Generation-Cephalosporin Resistance among Hospitalized Patients with Urinary Tract Infections Due to Escherichia coli: Do Rates Vary by Hospital Characteristics and Geographic Region?
    Bidell MR; Palchak M; Mohr J; Lodise TP
    Antimicrob Agents Chemother; 2016 May; 60(5):3170-3. PubMed ID: 26926640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 114 clinical isolates of Pseudomonas aeruginosa derived from urinary tract infections and their rapid detection by denaturing high-performance liquid chromatography.
    Matsumoto M; Shigemura K; Shirakawa T; Nakano Y; Miyake H; Tanaka K; Kinoshita S; Arakawa S; Kawabata M; Fujisawa M
    Int J Antimicrob Agents; 2012 Nov; 40(5):440-4. PubMed ID: 22884856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and molecular characterization of fluoroquinolone resistance in Escherichia coli isolates from dairy cattle with endometritis in China.
    Zhao HX; Zhao JL; Shen JZ; Fan HL; Guan H; An XP; Li PF
    Microb Drug Resist; 2014 Apr; 20(2):162-9. PubMed ID: 24224497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.